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Abstract

Emerging health record platforms are interesting
examples of the ongoing process of digitalization and
the great opportunities they provide for innovation
and additional services. Incumbent players are under
increasing pressure from new entrants to offer their
customers a user experience they have become
familiar with through platforms such as Apple and
Google. The emergence of the digital German health
record is shown as a case-study, harnessing a
longitudinal database and adopting a processsensitive perspective. Important events are structured
into individual episodes and phases and discussed indepth. The study shows how platform owners of health
records respond to changes in the highly regulated
healthcare system and its digitalization in Germany.
Contrasting
with
extant
knowledge
about
interoperability as a relevant precondition for
platforms, our study shows the important role played
by interoperability as a design parameter for
emerging platforms, which results in seven
interoperability
challenges
for
respective
stakeholders.

1. Introduction
Compared to other industries, the progress of
digitalization is much slower in the healthcare sector
[16]. Reasons include the necessary regulation within
divergent national contextual frameworks, the
presumption of market failure, the complex systems of
care and treatment processes, the variety of
stakeholders and heterogeneous systems and the lack
of interoperability (e.g., [19]). One of the key
applications, and the basis for various add-on services
in healthcare, is the Electronic Health Record (EHR),
which drives and underpins the digitalization of
healthcare. Due to the slow progress of digitalization,
the healthcare market still offers great potential for the
development of innovative services [16]. The
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chairman of the board of the Techniker Krankenkasse
(TK), one of the leading statutory health insurance
companies in Germany, communicated this very
clearly in his vision for the TK at a key speech in
October 2019:
"TKs vision for 2030 is shaped by the conviction
that people live in a few, relatively stable digital
ecosystems with high levels of connectivity. Besides
Apple and Amazon, a healthcare ecosystem is to be
designed by TK with a quality and user experience on
a par with Apple & Co. In this context, the regulatory
authorities in Germany will hopefully prevent
statutory health insurance companies from losing
direct contact with the customer during the transition
phase as well. The TK ecosystem will include databased services beyond the mandatory requirements
(e.g., electronic patient files) and will persuade and
inspire the loyalty of TK-insured persons in the long
term. We will clearly use digitization to differentiate
ourselves from the competition in order to achieve
greater control of the provision of care" 1 (Thomas
Ballast 2019; Board member TK, Berlin #eHealthCon
October 23, 2019).
In addition to this particular vision for the
healthcare sector by this insurance company, the quote
also elucidates the threat of new market entrants that it
will have to deal with and how it will address these
threats in terms of quality, user experience and service
offerings. Health record platforms play a central role
in this context. In order to develop the full potential of
EHR, semantic interoperability, in addition to
technical specifications, must be achieved despite its
being one of the most challenging tasks in health
informatics (e.g., [21]). Especially in the case of
providers of national EHRs, such as for Denmark or
Norway, a clear consensus about standards is
necessary to ensure the proper exchange of
information between different healthcare service
providers and sectors in order to realize the benefits of
platform-based coordination [14, 19, 1]. Germany's
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self-administered health system (consisting of
associations, institutes and organizations of
stakeholders in the health sector e.g., [23]) has not
been able to reach a consensus of interoperability
issues for decades. In 2019 and 2020, comprehensive
changes have taken effect in order to regulate the
digitalization of the German healthcare system records
and promote innovative health services. This refers in
particular to EHRs: by January 1, 2021, all statutory
health insurance companies are required by law to
provide their policyholders with an EHR. As of June
2020, six potential providers—two insurance
companies, Allgemeine Ortskrankenkasse (AOK) and
TK, and four service providers (VIVY, IBM,
Compugroup Medical and RISE)—have begun
developing an EHR in response to governmental
specifications. In the German context, health records
can be differentiated into one of two types, as shown
in Table 1. On the one hand, the EHR represents the
governmental required minimal standard of a
repository to store and exchange health status
information, which is securely stored and shared with
other institutions, based on the specifications of the
regulatory authorities. The EHR facilitates the
longitudinal sharing of medically relevant data, e.g.,
diagnosis, treatment activities, laboratory data and
radiology reports, which can be exchanged among
different health service providers across organizations
[4, 19] and is primarily administered by physicians.
On the other hand are provider-specific Personal
Health Records (PHR) which include personal health
information and which are primarily administered by
the user [4, 19]. PHRs are an additional optional
service of the EHR and provide the basis for data
generation as well as complementary offers of mostly
data-driven services within emerging providerspecific health ecosystems. In this context, and as
shown by Ballast’s quote above, it is in the interest of
providers such as TK and AOK to establish multisided health platforms, especially around the PHR, in
order to offer a competitive additional benefit to
interested insurants, by e.g. exclusive complementors
and their digital services. Both records will be
managed by the provider/platform owner, but in
contrast to the PHR, the EHR will have to follow
government specifications and regulations. Regarding
PHRs, each of the platform owners address different
interests and follow different design approaches over
the course of implementation as well as different
government structures and rules, e.g., relating to
openness [31] of their boundary resources (e.g., [13]).
Despite the fact that the EHR will only become
mandatory in 2021, competition between platforms
has already begun. In terms of interoperability, these
government requirements impose various challenges

for platform providers and platform owners. This leads
to the following two research questions:
RQ 1: How do PHR and their respective ecosystem
develop differently over time in a highly
regulated market?
RQ 2: Which specific interoperability challenges can
be observed prior to the official
implementation of EHRs in Germany?
In order to answer these questions, this study
follows a research design in digital transformation and
platformization (e.g., [11, 26]) in form of a
longitudinal,
processsensitive,
comparative,
embedded case study [9, 33]. The case will be
analyzed on the basis of primary data (e.g., fieldnotes
and interviews) and secondary data (e.g., press
releases, professional articles, legal reforms) which
will be compiled together in a digital case study
database following Yin’s approach [33]. In research
projects with long-term data, it is particularly
important to observe the research phenomenon as a
changing process over the development of the research
project; however, there are very few precedents of this
type of research (e.g., [11]). In the context of multisided platforms (MSP), Fürstenau et al. [11] developed
a design and management framework, which will be
used to analyze and compare the differences between
three selected PHR platforms in Germany during the
emergence process. The framework was developed by
Fürstenau et al. [11] as an extension of the integrative
framework for platforms by Gawer & Cusumano [12].
It specifies the four strategic design dimensions
(issues) manifested over the course of platform
development and contextualizes the design of
interoperability as an embedded and interdependent
design parameter.

2. Conceptual Background
2.1. Multi-Sided Platforms in Germany
Besides the described differences between PHRs
and EHRs, another differentiation exists between
government-regulated or open solutions [6], on a
regional, national or institutional level. Additionally,
the storage location of health records can be either
Table 1: Types of health records in Germany
Type

Regulation

EHR

Governmental
regulation

PHR

By the
platform
owner

Provider/
Platform
owner
Insurance
companies
Insurance
companies
or free
provider

Storage Location
Decentralized by
the service
provider
Centralized or
decentralized
depending on the
platform owner
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centralized or decentralized (see Table 1). In
Germany, the EHR will be a national, decentralized,
government-regulated solution, which means that the
data will be stored in the “primary information
system” of the service provider who generates the
EHR data. Other authorized service providers
throughout the nation can retrieve requested health
data. The data will be shared via the German health
information exchange infrastructure, which is a
nationwide secure Virtual Private Network (VPN),
called Telematic Infrastructure (TI). The technical
background processes as well as the user interface are
supplied by the EHR provider (see Table 1) via the TI.
Gematik as the lead organization is responsible for the
technical specifications, standards, testing and
operations of the TI. In contrast to the EHR, the PHR
is specified by the providers or platform owners.
Given that many different independent stakeholder
groups – medical service providers, complementors of
digital services, and patients – are involved, PHR
Platforms can be understood as an MSP [5, 19, 32].
The success of MSPs is significantly influenced by
network effects and a highly dynamic ecosystem [8,
26]. Kapoor [18] understands an ecosystem as “a set
of actors that contribute to the focal offer’s user value
proposition” [18 p. 2]. Its actors would include, e.g.,
participating physicians, complementors of digital
health services, insurants, and the insurance company.
Concerning platforms and their respective ecosystems,
Hein et al. [15] identified three central building blocks
of a digital platform ecosystem, consisting of platform
owner, value-creation mechanism and complementor.
The value-creation mechanism facilitates the joint
creation of value by the platform owner and
complementors and provides a basis for promoting
innovation within the platform ecosystem [15]. The
platform owner basically determines the design,
resources and management of the platform ecosystem
[15] according to Fürstenau et al.’s [11] design and
management framework. Choosing a mode of
governance [26] is the responsibility of the platform
owner, who also promotes innovation for the platform
ecosystem, especially by third-parties who are
respectively known as complementors [5].

2.2. Interoperability
Our understanding of interoperability is related to
the approach of the IEEE [17]. For MSPs, such as PHR
platforms, interoperability is an essential precondition
for exchanging data [10, 4, 3]. One requirement of
Fürstenau et al.’s [11] framework, and also a key
competitive parameter, is that the platform must be
able to achieve direct network effects through
standards and interfaces [8] as well as competitive

advantages through the design of the integration and
binding of complementors and customers. This
requires a certain degree of openness/closeness (e.g.,
[31]) within the platform’s ecosystem, which can be
achieved through the definition of governance rules
for the boundary resources (e.g., [13]) and the
selection of interface standards [27, 11]. In general,
interoperability can be achieved through the use of
standards, especially open standards. These standards
can be assigned to different levels of interoperability
according to their respective types. A distinction is
made between technical, syntactical, semantical and
pragmatic levels (e.g., [3, 25]). In order to implement
a PHR/EHR system, the technical level will be
represented by the IT architecture as well as its
compliance to the TI. Syntactical and semantical
interoperability refers to the format, especially
regarding the ease of understanding the transmitted
message. In order to benefit from the potential of
health records (e.g., big data and machine learning
algorithms), semantically interoperable data are
required [21], i.e., the exchanged information must be
able to be uniformly interpreted and understood (e.g.,
[3, 25]).

3. Method
3.1. Research design
In order to answer the research questions, an
essential understanding about the process and events
is required, especially regarding the regulatory
changes that will occur over the course of the
emergence of the EHR and PHR platforms in
Germany. These are part of an ongoing parallel and
sequential chain of events. We understand events to be
actions, reactions or decisions made by the platform
owners, conceivable complementors (stakeholders) or
government. Episodes are sequences of changes, e.g.,
by government, and resulting actions, reactions or
decisions made by platform owners or complementors,
as well as actions that occur during the process of the
platform’s emergence. The dissemination of health
platforms is dynamic, context-sensitive, and timespecific and requires a longitudinal analysis study
[32]. For a more nuanced understanding, the events
can be considered on different levels as well as in the
context of different issues in terms of platformization.
Therefore, we have chosen a longitudinal, processsensitive and comparative perspective with an indepth view of platformization according to the
platform management framework by Fürstenau et al.
[11]. The overall study is designed as embedded case
study following Eisenhardt [9] and Yin [33] and
focusses on contemporary events.
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3.2. Case selection and data collection

selection of decisive events during the emergence of
the EHR as well as the PHR platforms. In a further
Germany has one of the oldest healthcare systems
conceptualization, we distinguish between the
in the world. It follows a solidarity principle where
upcoming events of different, partly interdependent
every citizen is insured by one of the statutory health
levels of analysis in terms of the impact on the macro,
insurance providers (numbering 105, as of January 1,
meso or micro level (e.g., [22]). Events with a wide
2020), with the exception of certain professional
impact on the overall healthcare system can be
groups (e.g., soldiers, public servants, freelancers, or
assigned to the macro level, e.g., regulatory changes
high earners). Measured in terms of GDP, Germany
made by government. In contrast, the micro level will
has the third highest health expenditure [24]. A deeper
include events with a limited scope and impact, such
overview of the German healthcare system is provided
as in a single organization or a small focus group. The
by Obermann et al. [23] and Busse et al. [7]. Our study
meso level represents events in between the two, i.e.,
will focus on three emerging PHR platforms with the
events orchestrated by the platform owner for their
highest number of potential users and some interesting
ecosystem or for their insurants. Events on this level
strategic differences. Two of the platform owners
have a wider impact on all their insurants and/or the
belong to the largest statutory health insurance
respective ecosystem of the complementors of the
companies in Germany, the AOK and the TK. In
emerging PHR platforms.
contrast to these incumbent companies, the third
In terms of the emergence of the case, we identified
platform in our study is the entrant VIVY, a private
three overall phases for an initial structuring of the
company that offers a white label solution for statutory
information on the macro level in the data. During the
health insurance as well as for private insurance
first Phase, I Experimental PHR phase, the insurance
companies (see also [2]). Due to the high potential
companies in particular were able to gain initial
number of users and the significant differences in their
experience with a PHR. In the second phase,
PHR solutions, especially in terms of architecture,
II Transition phase from PHR to EHR, it became
these three providers are compared in a comparative
obvious that an EHR will become mandatory
case study approach [33]. While designing our case
according to specifications. In the third phase, III EHR
study, we reconstructed the process of episodes as well
becomes mandatory, the EHR will be introduced in
as the relevant events involving the respective actors,
Germany (on January 1, 2021). After this date, every
including regulatory changes over time, and thus the
statutory health insurance company must offer an EHR
emergence of the PHR platforms in Germany. We
to its insurants. To structure and reconstruct the events
used different sources of data to avoid potential biases
and episodes of the platform’s emergence, we follow
within the primary data, and triangulate the results
the four “issues” of Fürstenau et al.’s [11] platform
obtained from different sources of secondary data.
design and management framework. The issues follow
Table 2 presents an overview of the data used in the
a platform management point of view on the micro and
case study database [33].
meso level relating to the platform owner. The first
issue, 1) Developing strategy and governance model,
3.3. Data preparation and analysis
refers to decisions about the vision and governance
structures of the platform. Decisions about the
The collected data is coded and structured by level
architecture and interoperability of the platform can be
of analysis, time stamp and influence directions
coded as being part of the second issue, 2) Designing
according to the management framework developed
technical architecture and selecting standards. The
by Fürstenau et al. [11]. Additionally, the temporal
third issue, 3) Facilitating participation and
bracketing approach by Langley [20] is used to
community building, refers to actions and decisions
identify relevant events and episodes in the data. This
related to developing the community around the
structure enables a differentiation of the data and the
platform ecosystem. Decisions to form alliances with
Table 2: Case study database
Document type
Participatory
observations
Interviews

Press releases
Professional articles
Legal reforms
Specifications

Document description
Field notes from various events, including lectures and discussions by
responsible stakeholder (from November 2018–May 2020)
Semi-structured and formally recorded and transcribed interviews with health
startups (collected in 2019 as a pre-study)
Press releases, position papers, presentation slides, blog articles
Articles from professional digital health journals
Legal reforms to digitize the German healthcare (2004–2020)
Statements about the reforms that provide background information
Specification documents by regulatory authorities

Documents
31

Pages
112

7

72

59
28
6
20
6

246
212
598
125
422
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platforms or authorities can be assigned to the last
issue, 4) Engaging with the platform’s ecosystem and
wider environment. By structuring the data as
described, patterns and causal relationships can be
systematically established to reconstruct the case and
understand the impact of partially interlinked events
i.e. actions, reactions and decisions.

3.4. Case analysis of the emergence of health
record platforms in Germany
3.4.1. Introduction to the case analysis. This section
shows the dynamics within the emergence of the three
focused PHRs/EHRs in Germany over a period of
sixteen years. Starting from the regulatory changes on
the macro level, the three PHR platforms on the micro
and meso levels will be briefly explained. For this
purpose, the events are categorized into the three
distinct phases as well as the four issues identified by
Fürstenau et al. [11]. Figure 1 gives an overview, with
more details provided in the following subsections.
3.4.2. The case from the macro level point of view.
Initially, the emergence of health records can be
described from a macro perspective, i.e., essential
events, particularly governmental regulations and
legislation as well as the establishment of
infrastructure and the definition and selection of
standards, which relates especially to issues 1) and 2).
Phase I: Experimental phase of the PHR. The
first identified phase starts in 2004 (01 Jan. 2004)
when statutory health insurance companies were
legally allowed to finance PHRs to improve quality
and efficiency and to gain initial concrete experience
in day-to-day healthcare practice provided by
physicians. For twelve years (from 2004 to 2016), this
self-administration was not in any way centrally
managed or steered to provide a clear vision for the
PHRs to interface with that of other service providers
and to value-adding services to increase the
attractiveness of the Telematic Infrastructure (TI). In
December of 2018, gematik published the first version
of an EHR, which will require an integrated
application of the TI (19 Dec.2018). Contrary to expert
opinions and European solutions with established
standards, e.g., Integrated Healthcare Enterprises
(IHE), gematik decided to follow a proprietary noninternationally-standardized approach, which is not
interoperable with other existing solutions on a
technical or a syntactical level outside of the TI, i.e.
with that of other nations. The development of TI was
plagued by various problems, delays, inadequate
regulations, outdated technologies, etc. (e.g., [30]).
These were partly caused by disagreements among the
shareholders and stakeholders. Overall, this episode is

characterized by the failure of the system of selfadministration. The system could not gain sufficient
momentum without hierarchical regulatory guidelines,
due to direct and indirect network effects, and thus
failed to support widespread EHR/PHR solutions.
Vastly different particular interests (e.g., [28]) prevent
agreement
about
necessary
standards
and
specifications. After fourteen years, the government
lost patience and intervened to demand greater
consistency. In order to accelerate the process of
digitalization of the healthcare system, the Federal
Ministry of Health (FMH) took over the majority of
gematik through the Appointment Service and Care
Law (ASCL) (11 May 2019).
During this first phase, initial solutions from
German providers as well as internationally dominated
PHR platforms (e.g., Google, Apple, etc.), which are
also considered influential and relevant by PHR
platform ecosystems, became established, despite the
risk of as yet unknown standards and regulations.
Phase: II Transition phase from PHR to EHR.
With the ASCL (11 May 2019), wide-ranging
regulations for EHR were established, including a date
for the introduction of technical and infrastructural
regulations. Additionally, the responsibilities of
interoperability were clearly regulated and assigned
according to layers of interoperability. Gematik is in
charge of the technical and syntactical specifications
of the EHR, especially the infrastructure, and the
National Association of Statutory Health Insurance
Physicians (ASHIPs) is responsible for establishing
the syntactical and semantical specifications for the
EHR content. For this purpose, so-called Medical
Information Objects (MIO) are defined in order to
determine the structure for health documents (i.e.,
doctor's letter or vaccination certificate etc.) in the
EHR. Within this specification, the authorities define
the regulatory framework according to issue 2), of
Fürstenau et al. [11], regarding the design of the
architecture and standards of the EHR. Based on this,
the statutory health insurance companies can develop
their own EHR/PHR solution, which puts them in
direct competition with each other. With the resolution
of the Digital Health Service Law (DHSL), Germany
is the first country to enable the medical prescription
of approved Digital Health Services (DHS) i.e., health
apps (07 Nov. 2019) that will be financed by statutory
health insurance companies, as is clearly regulated by
the digital Health Applications Law (DHAL) (15 Jan.
2020). This allows potential complements (DHS) for
the PHRs/EHRs to be supported. The DHSs are also
subject to interoperability requirements in order to
transfer data to the EHR, which has been enforced by
the Patient Data Protection Law (PDPL) (11 Apr.
2020). This law represents a major breakthrough in
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terms of the semantical interoperability to build an
interoperable digital healthcare system based on
international standards with the acquisition of the
license of the international semantic standard
SNOMED CT. However, this only refers to the
semantic part of coding and the uniform understanding
of health information, but does not render the EHR
interoperable internationally.
Phase: III EHR becomes mandatory. According
to the ASCL, when the EHR will be introduced (01
Jan. 2021), each statutory health insurance company
must offer its insurants an EHR that will take effect on
January 1, 2021. One year later, the official financial
support for PHRs will end. There will only be a single
EHR for each insured person, as provided by his/her
health insurance company. Additionally, it must be
possible for insurants to transfer their data to another
health insurance provider in the EHR, if necessary (01
Jan. 2022).
3.4.3. The case of TK and AOK from the meso and
micro level point of view. In order to answer the
research question, how PHR and their respective
ecosystem develop differently over time in a highlyregulated market, we focus in this and the subsequent
section on the micro and meso level, i.e., the relevant
events during the emergence of the PHR platforms.
Initially, the parallels and differences of the incumbent
players AOK and TK are described in more detail,
whereas the entrant’s player VIVY will be described
in the next section (3.4.4. ).
Phase I: Experimental phase of the PHR. More
than twelve years after the PHR was financially
supported, the AOK is establishing a PHR solution (01
June 2016). For this purpose, the AOK, as the largest
association of health insurance companies with a total
of 26 million insurants, is choosing a decentralized
approach, i.e., the data will be stored by the healthcare
provider who creates the health data for its patient. In
terms of data access and exchange, the AOK is
following international standards, particularly IHE
integration profiles on technical and syntactical levels.
The AOK seeks to establish a health network for the
service providers, which relates to issue 3) by
Fürstenau et al. [11] (13 Sept. 2016 and 10 Oct. 2017).
The second largest health insurance company in
Germany with around ten million insurants is also
developing a PHR (21 Feb. 2017). In contrast to the
AOK, the TK are following a centralized approach to
data storage and developing the PHR together with
their cooperating company, IBM (IBM Watson, see
also [2]), which has many years of experience in datahosting and artificial intelligence (AI) in healthcare.
With regard to the above-cited vision of the TK, its
cooperation with IBM illustrates the added value that

the TK can offer. This enables TK to operate a
preventative care management by offering e.g. AIbased value-added services to its insurants. Despite the
different strategies and architectures (centralized/
decentralized) relating to issues 1) and 2 by Fürstenau
et al. [11], the two largest insurance companies, AOK
and TK decide to cooperate as co-opetition [27] (11Dec-2018) to enable data exchange among hospitals,
insurance companies and PHRs via an interface based
on the international IHE standard (11-Apr-2019).
Phase: II Transition phase from PHR to EHR.
Following the publication of the specifications by
gematik and ASHIP, both insurance companies (AOK
& TK) will be developing an EHR. Given the
differences between the existing PHR solutions and
the specified EHR in terms of architecture – according
to a decentralized approach and interoperability
following
non-internationally
standardized
approaches – both platform owners decided to
continue to offer their PHRs as an encapsulated
solution. With their PHR platform, platform owners
can offer complementary services to differentiate their
business from the competition, while retaining the
flexibility and control according to their own risk
aversion (development risks).
Relating to issue 4) Engaging with the platform’s
ecosystem and wider environment [11], the AOK
organized a community event with health startups to
expand its PHR ecosystem, and to attract innovative
services to their platform, as part of their offering to
their insurants (07 Nov. 2019).
Phase: III EHR becomes mandatory. As of
January 1, 2021, all statutory health insurance
companies are required by law to offer an EHR. One
year later, insurants have to be able to transfer their
EHR data to another statutory health insurance
company, to allow insurants to switch. However, this
only refers to interoperability of the specified EHR
and not the PHR itself. Thus, some personal data and
PHR specific services may not be transferable unless
explicitly stipulated by law.
3.4.4. The case of VIVY from the meso and micro
level point of view. VIVY and its main shareholder
Allianz (70%), offers a PHR solution for other health
insurance companies. With the Allianz-Group, VIVY
has an economically powerful partner which is one of
the world’s leading insurance groups. However,
Allianz in Germany focuses on private insurance and
asset management products. In contrast to AOK’s and
TK’s solutions, VIVY follows a centralized mobile
approach with a greater focus on user experience and
the autonomy of the data that comes through storing
the data encrypted on the insurants’ mobile devices
(see also [2]).
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Phase I: Experimental phase of the PHR. The IT
service provider of the statutory health insurance
companies (Bitmarck) assigned VIVY the contract to
provide a PHR for their customers (statutory health
insurance companies); therefore, VIVY became a
supplier of PHRs for private and statutory insurance
companies (01 May 2018). On September 17, 2018,
VIVY released its PHR. Consequently, VIVY became
the first platform owner of a PHR to provide a
nationwide solution for all insurants of the contractual
health insurance companies. This triggered network
effects and VIVY quickly acquired additional health
insurance companies (22 July 2019). At the time of
writing (Oct. 2020), VIVY’s ecosystem includes
twenty-nine statutory health insurance companies and
four private health insurance companies, each with
their own instance of PHR. A potential 19,4 million
insurants can use their PHR. Additionally, VIVY is
cooperating with several hospitals on the expansion of
their ecosystems (12-Aug-2019).
Phase: II Transition phase from PHR to EHR.
After the announced specification and date of the
EHR, VIVY will not offer an official EHR for
statutory health insurance companies. Its strategy for
this decision remains unclear, but may be based on the
large architectural differences between its product and
the general EHR specifications and regulatory

requirements, or based on the fact that the customer
group of the statutory insured do not fit the strategic
focus of its shareholders. Therefore, the contract has
been awarded to the provider RISE. Nevertheless,
VIVY will still be seen by the contract partner as a
provider of innovative solutions to connect
complementors e.g., digital health applications such as
Digital Health Service (DHS), and to offer innovative
health services via their mobile PHR solution.

4. Discussion
In order to answer the research questions, the key
events in the emergence of the EHRs and PHR
platforms were structured into phases and levels to
show—on the basis of longitudinal data—how the
ecosystems of the PHR platforms emerge. As a result,
interoperability challenges at single points of time
could be derived from the perspective of the respective
stakeholders.
Platform owners’ point of view: An initial
challenge is the appropriate 1) timing of designing
technical architecture and selecting standards,
reflecting issue 2) by Fürstenau et al. [11]. During
Phase I, the three platform owners have demonstrated
a possible PHR design, showing how an EHR could
potentially be structured in order to enter the

Figure 1. Emergence and dynamics of three PHR platforms in Germany
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discussion about technical and syntactical interface
specifications on the macro level with gematik and the
Association of Statutory Health Insurance Physicians,
among others, during the transition to Phase II. This
gives providers the opportunity to start diffusion
processes at an early stage to promote network effects
around their respective solutions and emerging
ecosystems. At the same time, there is an investment
and 2) the development risk of interfaces, especially in
times of uncertainty regarding the final specifications.
The uncertainty that characterized the transition from
phase I to phase II is likely to have resulted in costs
due to adjustments that had to be made to the
interfaces, especially on a technical and a syntactical
level. The platform owners AOK and TK have shown
how an interface can work according to international
standards, as it was to be expected that gematik would
follow these standards. However, the published
specification of the EHR does not follow IHE, the
established international standard. Due to the high
level of adaptation of the existing system, AOK and
TK decided to develop separate solutions according to
the national EHR specification. Therefore, the PHR
from AOK and TK will be offered as an additional
MSP-offering that fulfill the regulative basic
affordances of an EHR but maintain the control and
flexibility of the platform while promoting innovation
and avoiding further development risks for their
ecosystem. In contrast to the EHR, the platform
owners of the PHR are free to make decisions about
the design of the interfaces. This relates to issues 1)
and 3) by Fürstenau et al. [11], and the degree of
openness [31] via interfaces [27]. Platform owners
have to 3) choose the appropriate Governance Mode
[26] on the meso and micro levels of the platform’s
ecosystem for co-opetition with competitors, and
cooperation with complementors [27] regarding
interoperability requirements to promote innovations,
e.g., by complementors such as Digital Health Service
(DHS). The case of the co-opetition with the two
incumbents AOK and TK shows that two competitors
with partly different customer groups and a different
platform architecture can cooperate in order to avoid
being displaced by new entrants and to build solid and
partly interoperable PHR platforms.
Complementors’ point of view: This case also
highlights the challenges for complementors. This
includes 4) interoperability as a financing criterion of
digital health services e.g., health startups, to be
approved as (DHS) in the context of Germany.
Therefore, interoperability has to be an integral part of
the strategy to get financial support from statutory
health
insurance
companies.
Furthermore,
interoperability via standard interfaces is a basic
requirement of complementors connecting to

PHR/EHR platform ecosystems [3, 4, 10, 11]. In
Germany, this concerns at least five health startups
during Phase II that have officially approved as DHS
(fifteen have applied and will be reviewed, status as of
November 2020) in order to be prescribed by
physicians and reimbursed by the insurance
companies. The different architectures of the
platforms and governance modes of the platform
owners result in another challenge for the
complementors, namely to also 5) choose the
appropriate platform in terms of interoperability. In
addition to criteria relating to the size of the ecosystem
and to potential users of the platforms, interoperability
considerations are crucial, e.g., with regard to the type
and nature of the data/information needed from the
EHR and/or PHR. The adaptation effort to the PHR
platform would be relevant in this context for the
complementors. From a technical/syntactical point of
view, the complementors has to determine whether the
service requires the data/information from the EHR,
e.g., doctor's reports, examination results, or from the
PHR, such as self-collected vital parameters by the
insurants. AI-based services, for instance, as probably
intended e.g. by TK with its partner IBM Watson
require more stringent interoperability requirements
and semantic standards than less extensive services
[21]. Based on well-coded health data/information,
e.g., SNOMED CT, AI-based services can deliver
better results [21]. Another factor arises among the
different architectures of the platform (centralized/
decentralized) and respective access via e.g.,
standardized or less standardized interfaces – the
amount of effort necessary for the integration depends
on this. The respective adjustments and the threat of
switching costs (for additional platforms, etc.) results
in 6) binding effects for the complementors. Platform
owners try to avoid multihoming, for users as well as
complementors [29]. Detailed solutions within and
between the emerging platform ecosystems, especially
on a technical level, will be too different, e.g., in the
case of VIVY. The health data would be stored directly
on the device and could be accessed e.g., by Appbased services provided by the complementors,
whereas in the case of AOK, the data would be stored
in various decentralized IT infrastructures and would
have to be retrieved first. This included necessary
specifications for the concrete design and linking of
business and supply processes, the coding of treatment
and billing details, the supplementation of the
regulatory EHR mandatory elements, and additional
possibly ecosystem-specific value-added services.
Insurants’ point of view: The case also shows
some challenges for platform users, including the
patients/insurants. When an insurant decides to switch
their health insurance company, she/he can transfer
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her/his EHR-specified data to the platform of the new
statutory insurance company (from January 1, 2022).
However, this does not apply to the additional data
held in the PHR. Depending on the insurants’ personal
data and additional, in some cases PHRexclusive/specific services, switching costs will result.
This can lead to 7) lock-in effects to the initial platform
and thus to the respective statutory health insurance
company, effectively preventing multihoming by the
platform owners [34]. This aspect would also be
interesting regarding whether and what kind of role the
emerging tech platforms and ecosystems of Apple,
Google or Amazon, etc., will play and whether and
how their health services can be tackled, integrated or
combined with the respective PHR strategies by the
incumbents, as mentioned by Thomas Ballast in his
statement (p. 1). Apple, for example, is using the FHIR
standard to integrate further health services, and it
remains to be seen whether this will also apply to other
record solutions.

5. Limitations and outlook
The analysis and discussion of the case-study has
certain limitations and carries implications for further
research. In this study, the management and design
framework by Fürstenau et al. [11] was applied from
an external point of view, i.e., in some cases detailed
background information would be necessary to
elaborate on further instances. For the structuring of
the events, three supplementary event types
(governmental regulations, platform launch and nonspecific event) were used (see Figure 1). Some of the
identified aspects are closely linked to this specific
German case and are therefore not generally valid,
which would have to be examined individually in
future studies.
As a brief outlook for this case, three aspects merit
being further examined in future research. First, in
response to the initial TK quote, it will be interesting
to see if and how the relationship between the
incumbent ecosystems and international tech giants
like Google, Apple and Amazon will develop,
considering that they have stated their intention to
target health as their next big frontier. A “battle of the
platforms” can be expected, which will be shaped by
network effects and the decisions of complementors
and insurants as well as regulators in response to the
chosen strategies of the respective platform owners.
Second, platform owners have to compete with each
other for domination of the PHR/EHR market segment
from 2021 onwards. The effects their chosen strategies
will have on the attraction of complementors would
represent another avenue for future study, particularly
concerning platform architectures. Third, it would

help to understand the internal view of
complementors, including what challenges they
perceive and how they deal with them. The existing
demand for technical and economic strategies and
principles during the emergence of EHR and PHR
platforms in order to handle these challenges should
be addressed in further research, e.g., following a
design-oriented approach.

6. Conclusion
The study makes the following contributions: First,
in contrast to what we know about interoperability and
platforms as pre-conditions [3, 4, 10] and design
parameters [11, 19], especially in terms of openness
[27], this study reveals the central role played by
interoperability as a design parameter for emerging
MSPs, and contributes to the interoperability
discussions of MSPs, especially in healthcare. As part
of this we identified seven key challenges for
stakeholders, which are: For platform owners: 1) the
timing of designing technical architecture and
selecting standards, especially in periods of high
uncertainty, especially 2) to avoid the development
risk of interfaces and resulting adjustments; 3)
platform owners have to choose the appropriate
governance mode to balance interface openness, e.g.,
with
competitors
and
complementors.
4)
Interoperability can be a criterion for funding or
reimbursement and should form part of their strategy,
especially for complementors. 5) Complementors also
have to choose the appropriate platform to generate
interoperability i.e., interfaces and data composition.
6) Proprietary adaptations to an ecosystem can also
lead to binding effects. 7) From the perspective of the
insurants, there are also challenges resulting from the
lack of interoperability between PHR and other
platforms, which may result in lock-in effects for the
insurants to various, perhaps converging platforms of
incumbents and entrants in health as one of the next
big “digital transformation battle fields”. Second, a
discussion and comparison between PHR platforms
and the EHR points out the strategic differences
between the three providers, which also leads to
divergent architectural and interoperability challenges
for complementors, insurants, and not least for
platform owners themselves. Third, the study provides
an overview of the significant changes in the German
healthcare system triggered by digitalization and the
emergence of MSP platforms and the EHR. Fourth, the
discussion about the challenges has implications that
can inform researchers as well as insurance companies
or technical health service provider e.g. of health
platforms, in Germany and also in other countries.
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